WuXi AppTec Co., Ltd. (WUXIF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en Shanghai, China. El CEO actual es Ge Li.
WUXIF tiene fecha de IPO 2020-03-17, 39,414 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $41.41B.
WuXi AppTec Co., Ltd. is a leading contract research, development, and manufacturing organization headquartered in Shanghai, China. The company provides comprehensive services across the drug development lifecycle, including discovery, preclinical testing, clinical trials, and commercial manufacturing for small molecule drugs, biologics, and cell and gene therapies. Operating through six business segments—WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and others—the company serves pharmaceutical and biotech customers globally across China, Asia, the United States, Europe, and international markets. Founded in 2000, WuXi AppTec has established itself as an integrated solution provider that supports clients from early-stage drug discovery through commercialization across multiple therapeutic modalities.
